ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
SLAB
Silicon Laboratories Inc.
SLAB has the edge over ASTS overall, supported by lower modeled downside and stronger fundamentals.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SLAB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
SLAB's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
SLAB PE Valuation
SLAB has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SLAB Forward outlook
There aren't enough analyst estimates for SLAB to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
SLAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.61 | +$2.02 |
| Q2 2026 | -$1.17 | +$2.04 |
| Q1 2026 | -$1.52 | +$3.58 |
| Q4 2025 | -$1.98 | +$3.95 |
| Q3 2025 | -$2.63 | +$4.73 |
| Q2 2025 | -$3.21 | +$2.95 |
| Q1 2025 | -$5.10 | -$1.83 |
| Q4 2024 | -$5.93 | -$4.84 |
SLAB has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
SLAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $250.9M | +22% |
| Q2 2026 | $228.2M | +18% |
| Q1 2026 | $213.5M | +20% |
| Q4 2025 | $208.2M | +25% |
| Q3 2025 | $206M | +24% |
| Q2 2025 | $192.8M | +33% |
| Q1 2025 | $177.7M | +67% |
| Q4 2024 | $166.2M | +91% |
SLAB's revenue has grown year over year for eight quarters in a row: $251M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.2% | +9.2 points |
| Q2 2026 | -4.7% | +7.2 points |
| Q1 2026 | -8% | +10 points |
| Q4 2025 | -1.6% | +16 points |
| Q3 2025 | -6% | +12 points |
| Q2 2025 | -12% | +21 points |
| Q1 2025 | -18% | +38 points |
| Q4 2024 | -17% | +67 points |
SLAB has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
SLAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $40.5M | +45% |
| Q2 2026 | -$26.8M | -$23M |
| Q1 2026 | -$4.9M | -111% |
| Q4 2025 | -$1.6M | -126% |
| Q3 2025 | $27.9M | -5.1% |
| Q2 2025 | -$3.8M | -130% |
| Q1 2025 | $43.3M | +$117.1M |
| Q4 2024 | $6.2M | -58% |
SLAB has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
SLAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.6% | +546K shares |
| 1 year | +2.8% | +917K shares |
| 3 years | +5.2% | +1.7M shares |
| 5 years | -24% | -10.9M shares |
| Available history | -24% | -10.5M shares |
SLAB has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $16,000 |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $16M |
| Q2 2023 | $183.5M |
| Q1 2023 | $17.6M |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SLAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -402.1x | Net Cash |
| Q4 2023 | -117.5x | Net Cash |
| Q3 2023 | -1.2x | Net Cash |
| Q2 2023 | -1.3x | Net Cash |
| Q1 2023 | -5.6x | Net Cash |
| Q4 2022 | -3.5x | Net Cash |
| Q3 2022 | -4.1x | Net Cash |
| Q2 2022 | -6.4x | Net Cash |
SLAB has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
SLAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.2 | Neutral |
| Stochastic | 78.2 | Neutral |
SLAB's weekly RSI is 69 (neutral) and its Stochastic is 78 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
SLAB PE vs Technology Sector
| Metric | SLAB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
SLAB has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
SLAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 0.1% above |
| 20 week MA | $219.9 | 1% above |
| 50 week MA | $202.3 | 9.8% above |
| 100 week MA | $165.8 | 34% above |
| 200 week MA | $148.3 | 50% above |
SLAB has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
SLAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $116.5 | $126.3 | +8.4% |
| 2021 | $126.3 | $205.1 | +62% |
| 2022 | $205.1 | $134.7 | -34% |
| 2023 | $134.7 | $132.3 | -1.8% |
| 2024 | $132.3 | $127.8 | -3.4% |
| 2025 | $127.8 | $134.4 | +5.2% |
| 2026 YTD | $134.4 | $222.1 | +65% |
SLAB has the edge over ASTS on returns for 2026, with the stronger performance.